COVID-19 THERAPEUTICS ACCELERATOR

covid-19-therapeutics-accelerator-logo

COVID-19 Therapeutics Accelerator is a philanthropic collaboration supporting efforts to research, develop and bring effective treatments.

#Financial #More

COVID-19 THERAPEUTICS ACCELERATOR

Status:
Active

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Google Tag Manager WordPress Wordpress Plugins Sitelinks Search Box Yoast WordPress SEO Plugin Yoast SEO Premium


Investments List

Date Company Article Money raised
2021-12-07 Sosei Group COVID-19 Therapeutics Accelerator investment in Grant - Sosei Group N/A

More informations about "COVID-19 Therapeutics Accelerator"

Frequently Asked Questions - COVID-19 Therapeutics Accelerator

The COVID-19 Therapeutics Accelerator (CTA) was launched in March 2020 by Wellcome Trust, the Bill & Melinda Gates Foundation and Mastercard, with additional funding from a range of โ€ฆSee details»

The Access to COVID-19 Tools (ACT) Accelerator

The Access to COVID-19 Tools (ACT) Accelerator, is a new, groundbreaking global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines. ... ACT-Accelerator Facilitation โ€ฆSee details»

ACT-Accelerator FAQ - World Health Organization (WHO)

The Access to COVID-19 Tools (ACT) Accelerator is the worldโ€™s most comprehensive end-to-end solution to ending the acute phase of the devastating COVID-19 pandemic. It brings together โ€ฆSee details»

COVID-19 Therapeutics Accelerator | World Economic โ€ฆ

The COVID-19 Therapeutics Accelerator will work with the World Health Organization, government and private sector funders and organizations, as well as the global regulatory and policy-setting institutions. The Accelerator will โ€ฆSee details»

COVID-19 Therapeutics Accelerator - Bill & Melinda Gates โ€ฆ

The COVID-19 Therapeutics Accelerator will work with the World Health Organization, government and private sector funders and organizations, as well as the global regulatory and โ€ฆSee details»

Investments Made - COVID-19 Therapeutics Accelerator

Investments Made. As of October 26th, 2020, the COVID-19 Therapeutics Accelerator has awarded over $98 million in grants.See details»

ACT-A HSRC - World Health Organization

The Access to COVID-19 Tools Accelerator (ACT-A) is a global collaboration to accelerate the development, production, and equitable access to COVID-19 tools (diagnostics, therapeutics, โ€ฆSee details»

Announcing the COVID-19 Therapeutics Accelerator

Mar 8, 2020 Mark Suzman announces the COVID-19 Therapeutics Accelerator, a partnership between the Bill & Melinda Gates Foundation, Wellcome, and Mastercard. The initiative aims to identify potential treatments for COVID-19, โ€ฆSee details»

Unitaid and the access to COVID-19 tools accelerator

Jul 3, 2020 The urgent need for effective tools to limit the damage of COVID-19. The Access to COVID-19 Tools (ACT) Accelerator was launched in April 2020 by the World Health Organization and a range of global partners. The aim of this โ€ฆSee details»

ACT-Accelerator update - World Health Organization โ€ฆ

Jun 26, 2020 The therapeutics pillar is led by Unitaid and the Wellcome Trust (on behalf of the COVID-19 Therapeutics Accelerator) and seeks to accelerate the development and equitable delivery of treatments at all stages of disease, โ€ฆSee details»

COVID-19 Therapeutics Accelerator | Most Influential Projects

For letting the science lead the funding on potential COVID-19 treatments. Backed by major players ranging from Mastercard to The Bill & Melinda Gates Foundation to Wellcome, the โ€ฆSee details»

Propose a Treatment or Study - COVID-19 Therapeutics Accelerator

The COVID-19 Therapeutics Accelerator has prioritized proposals based on the following scoping criteria. Solutions should have suitability for low-resource settings, with global access through โ€ฆSee details»

Investing in COVID-19 Treatments - Bill & Melinda Gates Foundation

Apr 29, 2020 Trevor Mundel, President of the Bill & Melinda Gates Foundation's Global Health division, provides an update on the COVID-19 Therapeutics Accelerator. The Accelerator was โ€ฆSee details»

COVID Moonshot funded by COVID-19 Therapeutics Accelerator โ€ฆ

Sep 27, 2021 The COVID Moonshot, a non-profit, open-science consortium of scientists from around the world dedicated to the discovery of globally affordable and easily-manufactured โ€ฆSee details»

FUJIFILM Diosynth Biotechnologies Stands Ready to Manufacture โ€ฆ

HILLERØD, Denmark โ€“ FUJIFILM Diosynth Biotechnologies, a world leading Contract Development and Manufacturing Organization (CDMO) for biologics, viral vaccines and viral โ€ฆSee details»

CTA Donors - COVID-19 Therapeutics Accelerator

Founding and Core Donors Partnership is more important now than ever before. The Bill & Melinda Gates Foundation, Wellcome Trust, and Mastercard each committed seed funding to โ€ฆSee details»

COVID-19 Therapeutics Accelerator Donors Launch International โ€ฆ

The COVID-19 Therapeutics Accelerator will play a catalytic role by accelerating and evaluating new and repurposed drugs and biologics to treat patients with COVID-19 in the immediate โ€ฆSee details»

Coronavirus Treatment Acceleration Program (CTAP) | FDA

The development of COVID-19 therapeutics that are effective against current and future variants remains a critical priority. CTAP today remains vital to the expedited development of COVID-19 ...See details»

Therapeutics Accelerator Update - Bill & Melinda Gates Foundation

Apr 2, 2020 Itโ€™s been about three weeks since the foundation announced the COVID-19 Therapeutics Accelerator. What progress has been made? Yes. Thereโ€™s been a lot of โ€ฆSee details»